Three new aromatic sulfonamide inhibitors of carbonic anhydrases I, II, IV and XII

References

• Maren TH. (2000). Carbonic anhydrase inhibition in ophthalmology: Aqueous humour secretion and development of sulphonamide inhibitors. In Chegwidden WR, Carter ND, Edwards YH. The Carbonic Anhydrases New Horizonts. Basel: Birkhauser Verlag. pp. 425–436.
   Google Scholar
• Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003;23:146–189.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A, Conway J. (2004). Carbonic anhydrase: Its inhibitors and activators. London: CRC Press.
   Google Scholar
• Sugrue MF. New approaches to antiglaucoma therapy. J Med Chem 1997;40:2793–2809.
   PubMed Web of Science ®Google Scholar
• Sugrue MF. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Prog Retin Eye Res 2000;19:87–112.
   PubMed Web of Science ®Google Scholar
• Siesky B, Harris A, Brizendine E, Marques C, Loh J, Mackey J et al. Literature review and meta-analysis of topical carbonic anhydrase inhibitors and ocular blood flow. Surv Ophthalmol 2009;54:33–46.
   PubMed Web of Science ®Google Scholar
• Ponticello GS, Freedman MB, Habecker ChN Lyle, PA, Schwam H, Varga SL et al. Thienothiopyran-2-sulfonamides: A novel class of water-soluble carbonic anhydrase inhibitors. J Med Chem 1987;30:591–597.
   PubMed Web of Science ®Google Scholar
• Chen HH, Gross S, Liao J, McLaughlin M, Dean T, Sly WS et al. 2H-Thieno[3,2-e]- and [2,3-e]-1,2-thiazine-6-sulfonamide 1,1-dioxides as ocular hypotensive agents: Synthesis, carbonic anhydrase inhibition and evaluation in the rabbit. Bioorg Med Chem 2000;8:957–975.
   Google Scholar
• Mincione F, Starnotti M, Menabuoni L, Scozzafava A, Casini A, Supuran CT. Carbonic anhydrase inhibitors: 4-sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoyl-benzenecarboxamides with strong topical antiglaucoma properties. Bioorg Med Chem Lett 2001;11:1787–1791.
   PubMed Web of Science ®Google Scholar
• Maren TH. The development of topical carbonic anhydrase inhibitors. J Glaucoma 1995;4:49–62.
   PubMedGoogle Scholar
• Maren TH, Jankowska L, Sanyal G, Edelhauser HF. The transcorneal permeability of sulfonamide carbonic anhydrase inhibitors and their effect on aqueous humor secretion. Exp Eye Res 1983;36:457–479.
   PubMed Web of Science ®Google Scholar
• Jain A, Whitesides GM, Alexander RS, Christianson DW. Identification of two hydrophobic patches in the active-site cavity of human carbonic anhydrase II by solution-phase and solid-state studies and their use in the development of tight-binding inhibitors. J Med Chem 1994;37:2100–2105.
   PubMed Web of Science ®Google Scholar
• Remko M. Theoretical study of molecular structure and gas-phase acidity of some. Biologically active sulfonamides. J Phys Chem A 2003;107:720–725.
   Google Scholar
• Remko M, von der Lieth CW. Theoretical study of gas-phase acidity, pKa, lipophilicity, and solubility of some biologically active sulfonamides. Bioorg Med Chem 2004;12:5395–5403.
   PubMed Web of Science ®Google Scholar
• Remko M. Molecular structure, pKa, lipophilicity, solubility and absorption of biologically active aromatic and heterocyclic sulfonamides. Theochem J Mol Struct 2010;944:34–42.
   Web of Science ®Google Scholar
• Remko M, Kožíšek J, Semanová J, Gregáň F. Synthesis, crystal and molecular structure of two biologically active aromatic sulfonamides and their hydrochloride salts. J Mol Struct 2010;973:18–26.
   Google Scholar
• Cross PE, Gadsby B. Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 1. Substituted benzenedisulfonamides. J Med Chem 1978;21:845–850.
   Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–2573.
   PubMed Web of Science ®Google Scholar
• Pacchiano F, Carta F, Vullo D, Scozzafava A, Supuran CT. Inhibition of β-carbonic anhydrases with ureido-substituted benzenesulfonamides. Bioorg Med Chem Lett 2011;21:102–105.
   PubMed Web of Science ®Google Scholar
• Kolayli S, Karahalil F, Sahin H, Dincer B, Supuran CT. Characterization and inhibition studies of an α-carbonic anhydrase from the endangered sturgeon species Acipenser gueldenstaedti. J Enzyme Inhib Med Chem 2011;26:895–900.
   PubMed Web of Science ®Google Scholar
• Innocenti A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions. Bioorg Med Chem Lett 2009;19:1855–1857.
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Briganti F, Ilies MA, Supuran CT. Carbonic anhydrase inhibitors: Synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes. J Med Chem 2000;43:292–300.
   PubMed Web of Science ®Google Scholar
• Soltau JB, Zimmerman TJ. Changing paradigms in the medical treatment of glaucoma. Surv Ophthalmol 2002;47:2–5.
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G, Supuran CT. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: Is the tail more important than the ring? J Med Chem 1999;42:2641–2650.
   PubMed Web of Science ®Google Scholar
• Available at http://www.acdlabs.com/products/phys_chem_lab.
   Google Scholar
• Brechue WF. Topical carbonic anhydrase inhibitors: Physicochemical properties and aqueous humor dynamics. Rom Chem Quart Rev 1994;2:301–311.
   Google Scholar
• Abbate F, Coetzee A, Casini A, Ciattini S, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the antipsychotic drug sulpiride. Bioorg Med Chem Lett 2004;14:337–341.
   PubMed Web of Science ®Google Scholar
• Kim ChY Wittington, DA, Chang JS, Liao J, May JA, Christianson DW. Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IV. J Med Chem 2002;45:888–893.
   Google Scholar
• Vernier W, Chong W, Rewolinski D, Greasley S, Pauly T, Shaw M et al. Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: Structure-based drug design, synthesis, and biological evaluation. Bioorg Med Chem 2010;18:3307–3319.
   PubMed Web of Science ®Google Scholar